These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 22498647)

  • 21. Potent inhibition of cytochrome P450 2B6 by sibutramine in human liver microsomes.
    Bae SH; Kwon MJ; Choi EJ; Zheng YF; Yoon KD; Liu KH; Bae SK
    Chem Biol Interact; 2013 Sep; 205(1):11-9. PubMed ID: 23777987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A UPLC-MS/MS assay of the "Pittsburgh cocktail": six CYP probe-drug/metabolites from human plasma and urine using stable isotope dilution.
    Stewart NA; Buch SC; Conrads TP; Branch RA
    Analyst; 2011 Feb; 136(3):605-12. PubMed ID: 21107456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of stable isotope labeled probes to facilitate liquid chromatography/mass spectrometry based high-throughput screening of time-dependent CYP inhibitors.
    Dasgupta M; Tang W; Caldwell GW; Yan Z
    Rapid Commun Mass Spectrom; 2010 Aug; 24(15):2177-85. PubMed ID: 20583325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple P450 substrates in a single run: rapid and comprehensive in vitro interaction assay.
    Turpeinen M; Uusitalo J; Jalonen J; Pelkonen O
    Eur J Pharm Sci; 2005 Jan; 24(1):123-32. PubMed ID: 15626586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of an in vitro drug-drug interaction assay to simultaneously monitor five cytochrome P450 isoforms and performance assessment using drug library compounds.
    Zientek M; Miller H; Smith D; Dunklee MB; Heinle L; Thurston A; Lee C; Hyland R; Fahmi O; Burdette D
    J Pharmacol Toxicol Methods; 2008; 58(3):206-14. PubMed ID: 18634893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-throughput, 384-well, LC-MS/MS CYP inhibition assay using automation, cassette-analysis technique, and streamlined data analysis.
    Halladay JS; Delarosa EM; Tran D; Wang L; Wong S; Khojasteh SC
    Drug Metab Lett; 2011 Aug; 5(3):220-30. PubMed ID: 21867481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and full validation of six inhibition assays for five major cytochrome P450 enzymes in human liver microsomes using an automated 96-well microplate incubation format and LC-MS/MS analysis.
    Yao M; Zhu M; Sinz MW; Zhang H; Humphreys WG; Rodrigues AD; Dai R
    J Pharm Biomed Anal; 2007 May; 44(1):211-23. PubMed ID: 17418993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-throughput screening of inhibitory potential of nine cytochrome P450 enzymes in vitro using liquid chromatography/tandem mass spectrometry.
    Kim MJ; Kim H; Cha IJ; Park JS; Shon JH; Liu KH; Shin JG
    Rapid Commun Mass Spectrom; 2005; 19(18):2651-8. PubMed ID: 16124035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing higher throughput methods to assess drug-drug interactions for CYP1A2, CYP2C9, CYP2C19, CYP2D6, rCYP2D6, and CYP3A4 in vitro using a single point IC(50).
    Gao F; Johnson DL; Ekins S; Janiszewski J; Kelly KG; Meyer RD; West M
    J Biomol Screen; 2002 Aug; 7(4):373-82. PubMed ID: 12230892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatography-tandem mass spectrometry.
    Testino SA; Patonay G
    J Pharm Biomed Anal; 2003 Jan; 30(5):1459-67. PubMed ID: 12467917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro assessment of cytochrome P450 inhibition: strategies for increasing LC/MS-based assay throughput using a one-point IC(50) method and multiplexing high-performance liquid chromatography.
    Lin T; Pan K; Mordenti J; Pan L
    J Pharm Sci; 2007 Sep; 96(9):2485-93. PubMed ID: 17542019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of higher-throughput high-performance liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry assays to conduct cytochrome P450s CYP2D6 and CYP3A4 enzyme inhibition studies in human liver microsomes.
    Chu I; Favreau L; Soares T; Lin Cc; Nomeir AA
    Rapid Commun Mass Spectrom; 2000; 14(4):207-14. PubMed ID: 10669878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro interaction cocktail assay for nine major cytochrome P450 enzymes with 13 probe reactions and a single LC/MSMS run: analytical validation and testing with monoclonal anti-CYP antibodies.
    Tolonen A; Petsalo A; Turpeinen M; Uusitalo J; Pelkonen O
    J Mass Spectrom; 2007 Jul; 42(7):960-6. PubMed ID: 17565714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct and metabolism-dependent cytochrome P450 inhibition assays for evaluating drug-drug interactions.
    Lee KS; Kim SK
    J Appl Toxicol; 2013 Feb; 33(2):100-8. PubMed ID: 21915887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1.
    Bu HZ; Magis L; Knuth K; Teitelbaum P
    Rapid Commun Mass Spectrom; 2001; 15(10):741-8. PubMed ID: 11344532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and Validation of a Higher-Throughput Cytochrome P450 Inhibition Assay with the Novel Cofactor-Supplemented Permeabilized Cryopreserved Human Hepatocytes (MetMax Human Hepatocytes).
    Palacharla VRC; Chunduru P; Ajjala DR; Bhyrapuneni G; Nirogi R; Li AP
    Drug Metab Dispos; 2019 Oct; 47(10):1032-1039. PubMed ID: 31375472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry.
    Dierks EA; Stams KR; Lim HK; Cornelius G; Zhang H; Ball SE
    Drug Metab Dispos; 2001 Jan; 29(1):23-9. PubMed ID: 11124225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous determination of multiple CYP inhibition constants using a cocktail-probe approach.
    Zientek M; Youdim K
    Methods Mol Biol; 2013; 987():11-23. PubMed ID: 23475664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A sensitive and specific CYP cocktail assay for the simultaneous assessment of human cytochrome P450 activities in primary cultures of human hepatocytes using LC-MS/MS.
    Pillai VC; Strom SC; Caritis SN; Venkataramanan R
    J Pharm Biomed Anal; 2013 Feb; 74():126-32. PubMed ID: 23245243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absolute protein quantification of clinically relevant cytochrome P450 enzymes and UDP-glucuronosyltransferases by mass spectrometry-based targeted proteomics.
    Gröer C; Busch D; Patrzyk M; Beyer K; Busemann A; Heidecke CD; Drozdzik M; Siegmund W; Oswald S
    J Pharm Biomed Anal; 2014 Nov; 100():393-401. PubMed ID: 25218440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.